Bioequivalence study of ibuprofen 400 mg tablets
Journal Title: Revista Peruana de Medicina Experimental y Salud Publica - Year 2007, Vol 24, Issue 4
Abstract
[b][i]Objective.[/i][/b] To determine the bioavailability of two dosage forms of ibuprofen 400mg tablets, for establishing if the multisource (generic) drug is bioequivalent to the reference (Motrin® 400mg tablets). [b][i]Materials and methods.[/i][/b] It was designed an opened study, randomized, two periods, cross over, and seven days washout period, with 12 healthy volunteers (male and female), between 21 and 48 years old, who have taken one tablet of the multisource or reference tablets; according to randomization; with 200 mL of water. After drug intake 4 mL of blood was collected from each volunteer, for quantification of ibuprofen. The plasma samples with ibuprofen and sodium diclofenac(internal standard) were analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) with negative ion electrospray ionization using selected reaction monitoring. The bioequivalence was established with pharmacokinetics parameters: area under the curve AUC(0-t), AUC(0-∞) and maximum concentration (Cmax). [b][i]Results. [/i][/b]According to statistical analysis were founded: AUCmultisource(0-t) = 86.85 (ug*h)/mL, AUCRef.(0-t) = 81.20 (ug*h)/mL, AUCmultisource(0-∞) = 88.67 (ug*h)/mL, AUCRef.(0-∞) = 82.83 (ug*h)/mL, Cmáxmultisource = 17.70 ug/mL, CmáxRef.=18.09 ug/mL, with intervals of 0.93-1.24 for AUC(0-t), 0.93-1.24 for AUC(0-∞) and 0.81-1.19 for Cmax. [b][i]Conclusions.[/i][/b] The values founded for AUC(0-t), AUC(0-∞) and Cmax are within the established limits by WHO and FDA (0,80 -1,25), so ibuprofen 400mg tables; multisource drug, is bioequivalent to Motrin 400mg tablets, with regard to both the rate and extent of absorption.
Authors and Affiliations
Ofelia Villalva-Rojas, Miguel Grande-Ortíz, Juan Ortiz, Jacqueline Isasi, Dula Yantas, Víctor Fiestas
Keywords
Related Articles
- EP ID EP82946
- DOI -
- Views 114
- Downloads 0
Terremotos en el litoral central del Perú: ¿podría ser Lima el escenario de un futuro desastre?
En las páginas de la historia están registradas las amenazas del futuro. La historia sísmica del Perú muestra que vivimos en una zona de alta actividad sísmica, donde la ciudad de Lima ha sido protagonista en varias opor...
La carga de enfermedad y lesiones en el Perú y las prioridades del plan esencial de aseguramiento universal
Para la implementación del aseguramiento universal en salud en el Perú, se debe tener un paquete de cobertura de beneficios que debe ser financiado en forma obligatoria, el cual es denominado Plan Esencial de Aseguramien...
Características clínicas y moleculares de un brote de influenza en dos bases militares, Tumbes- Perú, 2007
[b][i]Objetivo.[/i][/b] Describir un brote de Influenza en dos bases militares en Tumbes, Perú. [b][i]Material y métodos. [/i][/b]Se utilizó la definición de caso de síndrome gripal del Ministerio de Salud en casos con m...
Prevalencia de anticuerpos contra Leptospira en personas asintomáticos y en perros de Chancay, Lima 2001
[b]Objetivos. [/b]Determinar la prevalencia de anticuerpos contra Leptospiras en personas asintomáticas dedicadas a la agricultura, pesca y comercio y en perros domésticos de localidades de Chancay (Huaral, Lima). Materi...
Implementation of universal health assurance in pilot regions of Peru
In April 2009, the Law No. 29344: Framework Law on Universal Health Assurance was enacted, its implementation will be gradual in the number of insured as coverage of benefits and explicit guarantees. First will be implem...